Literature DB >> 24403708

Anogenital warts in Northern Nigeria: A ten-year Review.

Saad Aliyu Ahmed1, Mohammed Sani Shehu1, Murtala Abubakar1, Suleiman Eneyamire Dauda1.   

Abstract

BACKGROUND: Anogenital warts are a common cause of morbidity affecting mainly the productive age group of the economy. Paucity of data in Nigeria necessitated this study.
MATERIALS AND METHODS: The pathology records of anogenital warts diagnosed in the Department of Pathology, Ahmadu Bello University Zaria between 1(st) January 2000 and 31(st) December 2009 were reviewed.
RESULTS: A total of 68 warts were diagnosed within the study period with anogenital warts constituting 39.7%. Majority of cases (62%) were in the 20-39 years age group (range: 5-50 years) and vulva was the most common site affected.
CONCLUSION: Genital warts are common in our environment, biopsy of suspicious lesions is recommended for diagnostic yield.

Entities:  

Keywords:  Anogenital; Nigeria; wart

Year:  2013        PMID: 24403708      PMCID: PMC3883230          DOI: 10.4103/0300-1652.122334

Source DB:  PubMed          Journal:  Niger Med J        ISSN: 0300-1652


INTRODUCTION

Warts are cutaneous and sometimes mucosal lesions caused by one of the several human papilloma virus (HPV) types. Several variants of warts occur depending primarily on the responsible HPV subtype and anatomic location of the lesion. Anogenital warts are HPV-associated warts involving the genital areas, the anal canal and the perineum; and it occurs in both genders. There is paucity of data relating to anogenital warts in our environment, necessitating a study that will serve as baseline for further studies in our setting. This study, therefore, aimed to describe the pattern of anogenital warts in a referral hospital in Northern Nigeria.

MATERIALS AND METHODS

This is a retrospective analysis of pathology records of anogenital warts diagnosed in the Department of Pathology, Ahmadu Bello University Teaching Hospital, Zaria between 1st January, 2000 and 31st December, 2009. Clinical data on each case was extracted from the respective copies of the request cards. The haematoxylin and eosin (H and E)-stained slides were retrieved in each case and reviewed by the authors. Where slides were missing or broken, fresh sections were taken from the paraffin-embedded tissue blocks of the specimens and stained. Relevant clinical and histopathological data were extracted and analysed. The results were presented in simple statistical tables.

RESULTS

Twenty-seven (27) patients were diagnosed with anogenital warts within the study period representing 39.7% of all patients with warts seen within the same period. The patients’ age ranged between 5 and 50 years. Most of the patients (41%) are in their 3rd decade of life. The Male:Female ratio is 1:3. The age and sex distribution is shown in Table 1.
Table 1

Age and sex distribution of anogenital warts

Age and sex distribution of anogenital warts In 15 (75%) of the female patients, the warts are located in the vulva, whereas the most common site in males is the peri-anal region (86%) [Table 2].
Table 2

Sex and anatomical site distribution of anogenital warts

Sex and anatomical site distribution of anogenital warts Tissue biopsy confirms human papiloma virus (HPV) infection in all the cases. The histological findings include nuclear atypia, koilocytosis, acanthosis, dyskeratosis and multinucleation. The rete ridges of the stratified squamous epithelium are elongated and thickened and chronic inflammatory infiltrate is usually present within the underlying connective tissue [Figure 1].
Figure 1

Shows the photomicrograph of condyloma acuminatum in a 24-year-old woman H&E Stain ×100

Shows the photomicrograph of condyloma acuminatum in a 24-year-old woman H&E Stain ×100

DISCUSSION

Anogenital warts (condyloma acuminata) are exophytic cauliflower-like lesions that are usually found near moist surfaces of the body. They may be observed in the perineum, anal canal, vulva, vagina and the shaft of the penis. Majority of the lesions are self-limiting and often regress spontaneously within 6 months to 6 years of onset of symptoms.1 Approximately 90% of all genital warts are related to human papiloma virus (HPV) types 6 and 11 which are least likely to have neoplastic potential.2 The differential diagnoses include squamous cell carcinoma, Bowen's disease, Molluscum contagiosum, Condylomata, Fibroepithelioma and Pearly penile papules.1 The female preponderance in this study is in keeping with what was reported by Andahi et al.,3 in North-eastern Nigeria, and by Okesola et al.,4 in South-western Nigeria. This may be explained by the increased incidence of warts in patients with veneral infections like Trichomonas vaginalis and Gardnerella, all of which have been documented to be more common in females.3 We found anogenital warts to be more prevalent in the 3rd decade of life. This corresponds with findings in studies elsewhere,5 and conforms to the general pattern established by previous studies that sexually transmitted diseases are more common in early adulthood.6 The predominant affectation of the vulva in females (75%) and anal canal in males (86%) in this study is in keeping with findings of Diclemente et al.,6 The moist vulva area favours the occurrence of genital warts, unlike the male external genitalia which is relatively drier due to less secretions than that of the female. Also, male circumcision which is widely practiced in our environment has a relatively protective effect on genital warts.78 Although gay sexual practice is reported to increase the incidence of anal warts in the male,910 its contribution to our findings cannot be assessed due to unavailability of such data.

CONCLUSION

Genital warts are common in our environment, biopsy of suspicious lesions is recommended for diagnostic yield.
  9 in total

1.  Circumcision in genital warts--let us not forget!

Authors:  S Dogra; B Kumar
Journal:  Sex Transm Infect       Date:  2003-06       Impact factor: 3.519

2.  Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study.

Authors:  Peter V Chin-Hong; Eric Vittinghoff; Ross D Cranston; Lynette Browne; Susan Buchbinder; Grant Colfax; Maria Da Costa; Teresa Darragh; Dana Jones Benet; Franklyn Judson; Beryl Koblin; Kenneth H Mayer; Joel M Palefsky
Journal:  J Natl Cancer Inst       Date:  2005-06-15       Impact factor: 13.506

3.  Association between sexually transmitted diseases and young adults' self-reported abstinence.

Authors:  Ralph J DiClemente; Jessica McDermott Sales; Fred Danner; Richard A Crosby
Journal:  Pediatrics       Date:  2011-01-03       Impact factor: 7.124

4.  Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men.

Authors:  S J Goldie; K M Kuntz; M C Weinstein; K A Freedberg; J M Palefsky
Journal:  Am J Med       Date:  2000-06-01       Impact factor: 4.965

Review 5.  Chapter 6: Epidemiology and transmission dynamics of genital HPV infection.

Authors:  Ann N Burchell; Rachel L Winer; Silvia de Sanjosé; Eduardo L Franco
Journal:  Vaccine       Date:  2006-06-02       Impact factor: 3.641

6.  Prevalence of human papilloma virus genital infections in sexually transmitted diseases clinic attendees in Ibadan.

Authors:  A O Okesola; O I Fawole
Journal:  West Afr J Med       Date:  2000 Jul-Sep

7.  Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type.

Authors:  Anna-Barbara Moscicki; Jonas H Ellenberg; Sepideh Farhat; Jiahong Xu
Journal:  J Infect Dis       Date:  2004-06-08       Impact factor: 5.226

8.  Human papillomavirus: epidemiology and public health.

Authors:  Mark Schiffman; Philip E Castle
Journal:  Arch Pathol Lab Med       Date:  2003-08       Impact factor: 5.534

9.  Male circumcision and human papillomavirus infection in men: a systematic review and meta-analysis.

Authors:  Natasha Larke; Sara L Thomas; Isabel Dos Santos Silva; Helen A Weiss
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.